288 related articles for article (PubMed ID: 17619904)
21. SULT1A1 Arg213His polymorphism, smoked meat, and breast cancer risk: a case-control study and meta-analysis.
Lee H; Wang Q; Yang F; Tao P; Li H; Huang Y; Li JY
DNA Cell Biol; 2012 May; 31(5):688-99. PubMed ID: 22011087
[TBL] [Abstract][Full Text] [Related]
22. The NAD(P)H:quinone oxidoreductase 1 gene polymorphism and lung cancer: differential susceptibility based on smoking behavior.
Xu LL; Wain JC; Miller DP; Thurston SW; Su L; Lynch TJ; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):303-9. PubMed ID: 11319169
[TBL] [Abstract][Full Text] [Related]
23. Oral contraceptive use and breast cancer risk: modification by NAD(P)H:quinone oxoreductase (NQO1) genetic polymorphisms.
Fowke JH; Shu XO; Dai Q; Jin F; Cai Q; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1308-15. PubMed ID: 15298951
[TBL] [Abstract][Full Text] [Related]
24. Arsenic methylation capability, myeloperoxidase and sulfotransferase genetic polymorphisms, and the stage and grade of urothelial carcinoma.
Huang SK; Chiu AW; Pu YS; Huang YK; Chung CJ; Tsai HJ; Yang MH; Chen CJ; Hsueh YM
Urol Int; 2009; 82(2):227-34. PubMed ID: 19322015
[TBL] [Abstract][Full Text] [Related]
25. NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.
Jamieson D; Wilson K; Pridgeon S; Margetts JP; Edmondson RJ; Leung HY; Knox R; Boddy AV
Clin Cancer Res; 2007 Mar; 13(5):1584-90. PubMed ID: 17332305
[TBL] [Abstract][Full Text] [Related]
26. Analysis of NQO1, GSTP1, and MnSOD genetic polymorphisms on lung cancer risk in Taiwan.
Lin P; Hsueh YM; Ko JL; Liang YF; Tsai KJ; Chen CY
Lung Cancer; 2003 May; 40(2):123-9. PubMed ID: 12711112
[TBL] [Abstract][Full Text] [Related]
27. [Genetic polymorphisms of NQO1, GSTT1, GSTM1 and susceptibility to chronic benzene poisoning].
Chen Y; Li GL; Ji ZY; Xu JN; Wu CL
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2005 Feb; 23(1):1-5. PubMed ID: 15748501
[TBL] [Abstract][Full Text] [Related]
28. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese.
Hamajima N; Matsuo K; Iwata H; Shinoda M; Yamamura Y; Kato T; Hatooka S; Mitsudomi T; Suyama M; Kagami Y; Ogura M; Ando M; Sugimura Y; Tajima K
Int J Clin Oncol; 2002 Apr; 7(2):103-8. PubMed ID: 12018106
[TBL] [Abstract][Full Text] [Related]
29. SULT1A1 genotype, active and passive smoking, and breast cancer risk by age 50 years in a German case-control study.
Lilla C; Risch A; Kropp S; Chang-Claude J
Breast Cancer Res; 2005; 7(2):R229-37. PubMed ID: 15743503
[TBL] [Abstract][Full Text] [Related]
30. A significantly joint effect between arsenic and occupational exposures and risk genotypes/diplotypes of CYP2E1, GSTO1 and GSTO2 on risk of urothelial carcinoma.
Wang YH; Yeh SD; Shen KH; Shen CH; Juang GD; Hsu LI; Chiou HY; Chen CJ
Toxicol Appl Pharmacol; 2009 Nov; 241(1):111-8. PubMed ID: 19686770
[TBL] [Abstract][Full Text] [Related]
31. NAD(P)H:quinone oxidoreductase 1 null genotype is not associated with pediatric de novo acute leukemia.
Sirma S; Agaoglu L; Yildiz I; Cayli D; Horgusluoglu E; Anak S; Yuksel L; Unuvar A; Celkan T; Apak H; Karakas Z; Devecioglu O; Ozbek U
Pediatr Blood Cancer; 2004 Oct; 43(5):568-70. PubMed ID: 15382274
[TBL] [Abstract][Full Text] [Related]
32. Investigation of NAD(P)H:quinone oxidoreductase 1 (NQO1) C609T polymorphism in prostate cancer.
Ergen HA; Gormus U; Narter F; Zeybek U; Bulgurcuoglu S; Isbir T
Anticancer Res; 2007; 27(6B):4107-10. PubMed ID: 18225579
[TBL] [Abstract][Full Text] [Related]
33. Sulfotransferase 1A1 polymorphism and gastric cancer risk: a pilot case-control study.
Boccia S; Persiani R; La Torre G; Rausei S; Arzani D; Gianfagna F; Romano-Spica V; D'Ugo D; Ricciardi G
Cancer Lett; 2005 Nov; 229(2):235-43. PubMed ID: 16137826
[TBL] [Abstract][Full Text] [Related]
34. [Study on genetic polymorphism of NQO1 and susceptibility to benzene poisoning].
Chen Y; Ji Z; Xu J; Wu C; Li G
Wei Sheng Yan Jiu; 2004 Nov; 33(6):657-9. PubMed ID: 15727169
[TBL] [Abstract][Full Text] [Related]
35. SULT1A1 genotype and susceptibility to colorectal cancer.
Lilla C; Risch A; Verla-Tebit E; Hoffmeister M; Brenner H; Chang-Claude J
Int J Cancer; 2007 Jan; 120(1):201-6. PubMed ID: 17013894
[TBL] [Abstract][Full Text] [Related]
36. No association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and risk of hepatocellular carcinoma development in Turkish subjects.
Akkiz H; Bayram S; Bekar A; Akgöllü E; Ülger Y; Kaya BY; Sandikçi M; Özdil B
Asian Pac J Cancer Prev; 2010; 11(4):1051-8. PubMed ID: 21133623
[TBL] [Abstract][Full Text] [Related]
37. [Relationship between hepatocellular carcinoma and the interaction between NQO1 polymorphisms and environmental factors].
Tan SK; Qiu XQ; Tang GF; Wang WW; Liu S
Zhonghua Gan Zang Bing Za Zhi; 2012 Nov; 20(11):833-7. PubMed ID: 23206302
[TBL] [Abstract][Full Text] [Related]
38. [Association between NAD(P)H: quinone oxidoreductase and apolipoprotein E gene polymorphisms in Alzheimer's disease].
Ma QL; Yang JF; Shao M; Dong XM; Chen B
Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(24):2124-7. PubMed ID: 14720419
[TBL] [Abstract][Full Text] [Related]
39. Role of NQO1 609C>T and NQO2-3423G>A polymorphisms in susceptibility to gastric cancer in Kashmir valley.
Malik MA; Zargar SA; Mittal B
DNA Cell Biol; 2011 May; 30(5):297-303. PubMed ID: 21294640
[TBL] [Abstract][Full Text] [Related]
40. A NAD(P)H:quinone oxidoreductase 1 polymorphism is a risk factor for human colon cancer.
Begleiter A; Hewitt D; Maksymiuk AW; Ross DA; Bird RP
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2422-6. PubMed ID: 17164365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]